early phase trials
Early Phase Trials: Reevaluating Asian Markets
February 10 by Pharma IQMuch has been made in recent years of the shift of research and development (R&D) activities, and in particular the movement of clinical trials to Asia and its rapidly expanding emerging markets...
Getting a Handle on PK Parameters
October 19 by Helen WinsorThomas Jaki, lecturer at Lancaster University and an expert in the estimation of PK parameters, joins Pharma IQ to discuss the challenges and changes in this area. Pharma IQ: Thomas, welcome. So,...
Challenges and Opportunities in the Use of Biomarkers in Early Phase Trials
October 07 by Pharma IQIn this interview Martin Jenkins, Senior Statistician at AstraZeneca, speaks to Andrea Charles from Pharma IQ, about exploring the potential uses of biomarkers to enhance early clinical development,...
